EQJ-30920-99549
1 vaccination
5 coded responses
13 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 850 / AZ
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-06
Dose 1 — Pfizer-BioNTech
-
2021-04-07
Registered in v-safe
- 2021-04-07
-
2021-04-08
Survey response — days 1–6 daily, dose 1MedDRA: Arthritis, Cystitis interstitial, Fibromyalgia — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Primarily exacerbation of existing arthritis, fibromyalgia and interstitial cystitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-20
Survey response — day 14, dose 1MedDRA: Immunisation reaction, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Severe rash, needing urgent care visit. This started soon after vaccine administered. Have been advised to consider skipping dose #2.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-27
Survey response — day 21, dose 1MedDRA: Injection site induration, Injection site pain, Office visit, Rash, Sleep disorder — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Severe rash over multiple areas of body, including throat and eye. Arm where injection applied painful and stiff. Sleep interrupted by itching. PCP said not to get 2nd dose. · Healthcare visit (other): 2nd visit was to PCP in office.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Report sent to call center — day 21, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-04
Survey response — day 28, dose 1MedDRA: Office visit, Rash, Visual impairment — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Severe rash now threatening eyesight. Have seen: urgent care, PCP, and will see allergist tomorrow. · Healthcare visit (other): PCP seen, referred to allergistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Report sent to call center — day 28, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-11
- 2021-05-18
- 2021-07-06
-
2021-10-05
Survey response — 6 months, dose 1MedDRA: Hypersensitivity, Rash — Feeling: Poor · Be unable to do your normal daily activitiesFree text: The rash accompanying my allergic reaction has returned.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-01
- 2022-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-06 | Pfizer-BioNTech |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Primarily exacerbation of existing arthritis, fibromyalgia and interstitial cystitis
Release 7 — day 14, dose 1
Symptoms: Severe rash, needing urgent care visit. This started soon after vaccine administered. Have been advised to consider skipping dose #2.
Release 8 — day 21, dose 1
Symptoms: Severe rash over multiple areas of body, including throat and eye. Arm where injection applied painful and stiff. Sleep interrupted by itching. PCP said not to get 2nd dose.
Healthcare visit (other): 2nd visit was to PCP in office.
Release 8 — day 28, dose 1
Symptoms: Severe rash now threatening eyesight. Have seen: urgent care, PCP, and will see allergist tomorrow.
Healthcare visit (other): PCP seen, referred to allergist
Release 10 — 6 months, dose 1
Symptoms: The rash accompanying my allergic reaction has returned.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Immunisation reaction | ✓ | ✓ | ✓ |
| SD | Injection site induration | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Office visit | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Sleep disorder | ✓ | ✓ | ✓ |
| SD | Visual impairment | ✓ | ✓ | ✓ |
| SRO | Arthritis | ✓ | ✓ | ✓ |
| SRO | Cystitis interstitial | ✓ | ✓ | ✓ |
| SRO | Fibromyalgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release